Invention Grant
- Patent Title: Methods of treating disorders with Group I mGluR antagonists
- Patent Title (中): 用I组mGluR拮抗剂治疗疾病的方法
-
Application No.: US11015328Application Date: 2004-12-17
-
Publication No.: US07648993B2Publication Date: 2010-01-19
- Inventor: Mark F. Bear , Kimberly M. Huber , Stephen T. Warren
- Applicant: Mark F. Bear , Kimberly M. Huber , Stephen T. Warren
- Applicant Address: US RI Providence US GA Atlanta
- Assignee: Brown University,Emory University
- Current Assignee: Brown University,Emory University
- Current Assignee Address: US RI Providence US GA Atlanta
- Agency: Hamilton, Brook, Smith & Reynolds, P.C.
- Main IPC: A61K31/435
- IPC: A61K31/435 ; A61K31/33
Abstract:
mGluR5 antagonists are used for the treatment and prevention of disorders, including Fragile X, autism, mental retardation, schizophrenia and Down's Syndrome. The methods of the invention can be used to treat epilepsy and anxiety in a human having Fragile X syndrome, autism, mental retardation, schizophrenia and Down's Syndrome.
Public/Granted literature
- US20050171067A1 Methods of treating disorders with group I mGluR antagonists Public/Granted day:2005-08-04
Information query
